Clincosm LogoSign in Get a demo

chronic obstructive pulmonary disease (copd)

Showing 26 - 50 of 328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD (COPD) Trial in China (TQC3721 suspension for inhalation, TQC3721 suspension for inhalation)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • TQC3721 suspension for inhalation
  • TQC3721 suspension placebo for inhalation
  • Chongqing, Chongqing, China
  • +10 more
Jun 1, 2022

COPD (COPD) Trial in Macquarie Park (Lung Sealant, Endobronchial Valve (EBV))

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Sealant
  • Endobronchial Valve (EBV)
  • Macquarie Park, New South Wales, Australia
    Macquarie University
May 24, 2022

COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • (no location specified)
Apr 26, 2022

Significative Items Aimed at Improving Health Care Procceses.

Recruiting
  • Parkinson Disease
  • +4 more
    • Valencia, Spain
      Instituto de Biomecánica de Valencia
    Apr 26, 2022

    COPD (COPD) Trial in Edmonton (Canadian Standardized PR, Traditional PR)

    Completed
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Canadian Standardized PR
    • Traditional PR
    • Edmonton, Alberta, Canada
      G. F. MacDonald Centre for Lung Health
    Apr 6, 2022

    Airway, Blood and/or Urine Specimens From Research Studies

    Recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • +5 more
      • New York, New York
        Weill Cornell Medical College and Weill Cornell Medical Center,
      Mar 29, 2022

      COPD (COPD) Trial (Tesamorelin, Placebo)

      Terminated
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • (no location specified)
      Mar 9, 2022

      COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • BFF
      • Symbicort Turbuhaler
      • Frankfurt/Main, Germany
      • +3 more
      Feb 21, 2022

      COPD (COPD) Trial in Israel (SenseGuard Investigational Device)

      Recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • SenseGuard Investigational Device
      • Ashkelon, Israel
      • +3 more
      Mar 14, 2022

      Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

      Recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Reveal LINQ
      • Brandon, Florida
      • +7 more
      Mar 10, 2022

      COPD (COPD) Trial in Portland (TD-4208, Placebo)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Portland, Oregon
        Allergy Associates Research Center (AARC)
      Feb 22, 2022

      COPD (COPD) Trial in Easley (TD-4208, Tiotropium)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Easley, South Carolina
        Palmetto Medical Research Associates L.L.C
      Feb 22, 2022

      COPD (COPD) Trial in Lincoln (TD-4208)

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Lincoln, Nebraska
        Celerion
      Feb 22, 2022

      COPD (COPD) Trial in Easley (TD-4208, Placebo)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Easley, South Carolina
        Palmetto Medical Research Associates L.L.C.
      Feb 22, 2022

      COPD (COPD) Trial in United States (Revefenacin, Placebo, Formoterol)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Miami, Florida
      • +11 more
      Feb 22, 2022

      COPD (COPD) Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Mometasone furoate/formoterol (MF/F) combination
      • +3 more
      • (no location specified)
      Feb 7, 2022

      COPD (COPD) Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Mometasone furoate/formoterol (MF/F) combination
      • +3 more
      • (no location specified)
      Feb 7, 2022

      COPD (COPD) Trial in Bordeaux (Seretide® Diskus® 500/550 µg, Ultibro® Breezhaler® 110/50 µg, Spiriva® Respimat® 2,5 µg)

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Seretide® Diskus® 500/550 μg
      • +2 more
      • Bordeaux, France
        CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
      Feb 8, 2022

      COPD (COPD), Exacerbation Copd, Muscle Atrophy Trial in Montpellier (Comparison of clinical and biological characteristics of

      Terminated
      • Chronic Obstructive Pulmonary Disease (COPD)
      • +2 more
      • Comparison of clinical and biological characteristics of patients
      • Montpellier, France
        Montpellier University Hospital Arnaud de Villeneuve Hospital
      Dec 20, 2021

      COPD (COPD) Trial in Surakarta (pedometer home based rehabilitation, Exercise training)

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • pedometer home based rehabilitation
      • Exercise training
      • Surakarta, Central Java, Indonesia
        Pulmonary department of medical faculty Universitas Sebelas Mare
      Oct 17, 2021

      COPD (COPD) Trial in Nadarzyn, Lodz (Beclometasone/Formoterol/Glycopyrrolate)

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Nadarzyn, Mokra 7, Poland
      • +1 more
      Oct 28, 2021

      COPD (COPD) Trial in Parma (drug, procedure, other)

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • CHF 5993 + Ultibro matched placebo
      • +6 more
      • Parma, Italy
        Chiesi Farmaceutici S.p.A.
      Oct 28, 2021

      COPD (COPD) Trial in Manchester (Glycopyrrolate, Tiotropium, )

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Manchester, United Kingdom
        Medicines Evaluation Unit
      Oct 28, 2021

      Host-response Based Diagnostic for Distinguishing Between

      Completed
      • Lower Respiratory Tract Infection
      • +4 more
        • Haifa, Israel
          Rambam Health Care Campus
        Oct 4, 2021

        COPD (COPD) Trial in Rennes (Hypnosis + NIV, NIV)

        Not yet recruiting
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Hypnosis + NIV
        • NIV
        • Rennes, Bretagne, France
          Rennes University Hospital
        Sep 27, 2021